JP2023538963A5 - - Google Patents
Info
- Publication number
- JP2023538963A5 JP2023538963A5 JP2023513939A JP2023513939A JP2023538963A5 JP 2023538963 A5 JP2023538963 A5 JP 2023538963A5 JP 2023513939 A JP2023513939 A JP 2023513939A JP 2023513939 A JP2023513939 A JP 2023513939A JP 2023538963 A5 JP2023538963 A5 JP 2023538963A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- responsive
- subjects
- classifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073336P | 2020-09-01 | 2020-09-01 | |
| US63/073,336 | 2020-09-01 | ||
| PCT/US2021/048346 WO2022051245A2 (en) | 2020-09-01 | 2021-08-31 | Methods and systems for predicting response to anti-tnf therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538963A JP2023538963A (ja) | 2023-09-12 |
| JP2023538963A5 true JP2023538963A5 (enExample) | 2024-08-26 |
Family
ID=80492102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513939A Pending JP2023538963A (ja) | 2020-09-01 | 2021-08-31 | 抗ｔｎｆ治療に対する応答を予測するための方法およびシステム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230282367A1 (enExample) |
| EP (1) | EP4208256A4 (enExample) |
| JP (1) | JP2023538963A (enExample) |
| KR (1) | KR20240018404A (enExample) |
| CN (1) | CN117615780A (enExample) |
| AU (1) | AU2021336781A1 (enExample) |
| CA (1) | CA3191195A1 (enExample) |
| GB (1) | GB2616129A (enExample) |
| IL (1) | IL300978A (enExample) |
| MX (1) | MX2023002446A (enExample) |
| WO (1) | WO2022051245A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019178546A1 (en) | 2018-03-16 | 2019-09-19 | Scipher Medicine Corporation | Methods and systems for predicting response to anti-tnf therapies |
| JP2022541125A (ja) | 2019-06-27 | 2022-09-22 | サイファー メディシン コーポレーション | 患者を層別化するための分類子の開発 |
| WO2023150731A2 (en) * | 2022-02-04 | 2023-08-10 | Scipher Medicine Corporation | Systems and methods for predicting response to anti-tnf therapies |
| CN120015309B (zh) * | 2025-01-14 | 2025-12-12 | 中国人民解放军军事科学院军事医学研究院 | 用于急性高原反应（ams）易感性分群的装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2165194A4 (en) * | 2007-05-31 | 2010-09-08 | Abbott Lab | BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES |
| SG182183A1 (en) * | 2007-06-08 | 2012-07-30 | Biogen Idec Inc | Biomarkers for predicting anti-tnf responsiveness or non-responsiveness |
| JP2012500993A (ja) * | 2008-08-25 | 2012-01-12 | ヤンセン バイオテツク，インコーポレーテツド | 潰瘍性大腸炎及び関連した疾患における抗ｔｎｆ処置のためのバイオマーカー |
| WO2011014349A1 (en) * | 2009-07-28 | 2011-02-03 | Centocor Ortho Biotech Inc. | Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis |
| CA3295783A1 (en) * | 2011-05-10 | 2026-03-02 | Prometheus Laboratories, Inc. | Methods of disease activity profiling for personalized therapy management |
| JP7054990B2 (ja) * | 2014-03-27 | 2022-04-15 | ジェネンテック， インコーポレイテッド | 炎症性腸疾患の診断及び治療のための方法 |
| GB201521357D0 (en) * | 2015-12-03 | 2016-01-20 | Univ Liverpool | Methods for predicting response to anti-TNF therapy |
| EP3654993A4 (en) * | 2017-07-17 | 2021-08-25 | The Broad Institute, Inc. | CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA |
| WO2019178546A1 (en) * | 2018-03-16 | 2019-09-19 | Scipher Medicine Corporation | Methods and systems for predicting response to anti-tnf therapies |
| EP3881233A4 (en) * | 2018-11-15 | 2022-11-23 | Ampel Biosolutions, LLC | DISEASE PREDICTION AND TREATMENT PRIORIZATION WITH MACHINE LEARNING |
| CA3119294A1 (en) * | 2018-11-15 | 2020-05-22 | Janssen Biotech, Inc. | Methods and compositions for prediction of response to a therapy of inflammatory bowel disease |
| JP2022541125A (ja) * | 2019-06-27 | 2022-09-22 | サイファー メディシン コーポレーション | 患者を層別化するための分類子の開発 |
-
2021
- 2021-08-31 WO PCT/US2021/048346 patent/WO2022051245A2/en not_active Ceased
- 2021-08-31 GB GB2303624.7A patent/GB2616129A/en active Pending
- 2021-08-31 CA CA3191195A patent/CA3191195A1/en active Pending
- 2021-08-31 MX MX2023002446A patent/MX2023002446A/es unknown
- 2021-08-31 EP EP21864967.1A patent/EP4208256A4/en not_active Withdrawn
- 2021-08-31 CN CN202180074291.7A patent/CN117615780A/zh active Pending
- 2021-08-31 JP JP2023513939A patent/JP2023538963A/ja active Pending
- 2021-08-31 AU AU2021336781A patent/AU2021336781A1/en not_active Abandoned
- 2021-08-31 KR KR1020237011014A patent/KR20240018404A/ko active Pending
- 2021-08-31 IL IL300978A patent/IL300978A/en unknown
-
2023
- 2023-02-28 US US18/176,288 patent/US20230282367A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7297015B2 (ja) | エピジェネティックな染色体相互作用 | |
| JP2021518432A5 (enExample) | ||
| GB2603294A (en) | Developing classifiers for stratifying patients | |
| US11091809B2 (en) | Molecular diagnostic test for cancer | |
| US10260097B2 (en) | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent | |
| JP2022541125A5 (enExample) | ||
| GB2616129A (en) | Methods and systems for predicting response to anti-TNF therapies | |
| Dix et al. | Biomarker-based classification of bacterial and fungal whole-blood infections in a genome-wide expression study | |
| CA2852954A1 (en) | Methods for improving inflammatory bowel disease diagnosis | |
| CN107523626B (zh) | 一组用于活动性肺结核无创诊断的外周血基因标记物 | |
| WO2016050111A1 (en) | Biomarkers for rheumatoid arthritis and usage thereof | |
| CN113755596B (zh) | 一种检测喉鳞癌放疗敏感性相关基因atm和atr基因突变的试剂盒及其应用 | |
| GB2622147A (en) | Methods of classifying and treating patients | |
| CN107058521A (zh) | 一种检测人体免疫状态的检测系统 | |
| CN112481380A (zh) | 一种评估晚期膀胱癌抗肿瘤免疫治疗反应性和预后生存的标志物及其应用 | |
| JP2024521748A (ja) | 潰瘍性大腸炎に関与する遺伝子の抗ｉｌ－２３ｐ１９抗体調節 | |
| JP2023536636A5 (enExample) | ||
| US20170145501A1 (en) | Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response | |
| EP3652749A1 (en) | Novel methods of predicting transplant rejection risk | |
| Pu et al. | Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next? | |
| WO2012149107A2 (en) | Stratifying patient populations through characterization of disease-driving signaling | |
| HK40100171A (en) | Methods and systems for predicting response to anti-tnf therapies | |
| CN110511995A (zh) | 一组结核病标志物及其应用 | |
| WO2016090255A1 (en) | Biological markers for predicting responsiveness to ibrutinib and r-chop combination therapy and methods of using the same | |
| Blundell et al. | Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When? |